Dr. Jona A. Hattangadi-Gluth's lab focuses on understanding how radiation therapy affects cognitive function in patients with glioma, a type of brain tumor. The team conducts studies to identify the factors that influence cognitive decline after treatment and aims to develop interventions that can protect brain function during radiation therapy. They use advanced imaging techniques and cognitive assessments to explore the connections between brain injury and cognitive performance over time, with the ultimate goal of improving patient outcomes and addressing health disparities.

Dr. Tzahi Cohen-Karni's lab at Carnegie-Mellon University focuses on understanding how DNA damage in heart cells can lead to heart disease. They explore the molecular mechanisms behind cardiac health by studying how damaged DNA affects cell communication and function in 3D heart tissue models. Their work aims to identify potential new treatments for heart failure and improve our understanding of how DNA damage impacts heart health.

Dr. Joel Collier's lab at Duke University focuses on developing new types of treatments for chronic inflammatory diseases like inflammatory bowel disease and rheumatoid arthritis. Instead of using traditional antibody therapies that may not work for all patients, the lab designs innovative biomaterials that help the body's immune system generate its own healing responses. This involves creating smart materials that can help reduce inflammation and improve overall health outcomes with less frequent treatments.

Dr. Stephanie Grace Cone's lab at the University of Delaware focuses on understanding Achilles tendinopathy, a common condition that causes pain and limits activity. By looking closely at the unique anatomy of the Achilles tendon and muscle-subtendon units, the lab aims to improve treatment strategies that are currently ineffective for many patients. They use advanced imaging techniques and modeling to tailor interventions to the specific structures and needs of individual patients for better outcomes.

Dr. Steven Conolly's lab at UC Berkeley is focused on advancing a new imaging technology called Magnetic Particle Imaging (MPI). This technology aims to provide rapid, non-invasive imaging without radiation, crucial for monitoring treatments like CAR-T immunotherapy and diagnosing conditions like strokes and pulmonary embolisms. By improving the spatial resolution of MPI, the lab seeks to enhance medical imaging capabilities significantly, making diagnoses faster and safer.

Professor Keith E Cook's lab at Carnegie-Mellon University focuses on innovative ways to improve patient care during extracorporeal membrane oxygenation (ECMO) for those suffering from severe lung diseases. The research aims to develop advanced biomaterials that can help prevent excessive bleeding and blood clots in ECMO circuits, ultimately improving survival rates and easing patient treatment outside intensive care settings.

Dr. Kara E. Garcia's lab focuses on understanding the mechanics of brain development, particularly how brain folds form in infants. They investigate the factors that influence brain structure, especially during the crucial stages of growth in the womb and shortly after birth. By using advanced MRI techniques and computational modeling, they aim to link these developmental processes to various neurological and psychiatric disorders.

Dr. Rachelle L Crescenzi's research lab at the University of Virginia focuses on using advanced MRI techniques to better understand and diagnose lymphatic diseases, particularly lymphedema and lipedema. By developing a method called Sodium Adipose and Lymphatics Translational (SALT) MRI, the lab seeks to visualize how sodium accumulates in these conditions and aims to enhance clinical imaging to guide treatment. Their work not only aims to improve diagnostic strategies but also strives to pave the way for new therapeutic approaches in managing lymphatic disorders.

Dr. Xinyan Tracy Cui's lab focuses on understanding the effects of traumatic brain injury (TBI) on cognitive and emotional functions. Using cutting-edge technology, the lab develops flexible neural probes that can monitor brain activity and neurotransmitter levels over time. By investigating how TBI impacts dopamine and glutamate neurotransmission, the lab aims to uncover mechanisms underlying cognitive-affective symptoms and enhance treatment strategies for TBI patients.

Dr. Kathleen E. Cullen's lab at Johns Hopkins University focuses on understanding how the brain processes balance and motion through the vestibular system, which is crucial for maintaining stability and clear vision. The lab's research aims to uncover the mechanisms by which the cerebellum helps the brain differentiate between self-generated and external motion effects. Additionally, they are working on developing innovative treatments like vestibular prostheses to assist individuals who have lost their balance sensations due to disease or aging.

Dr. Joseph P. Culver's lab focuses on developing innovative optical imaging techniques to study brain development in children, particularly those with autism spectrum disorder (ASD). By creating a lightweight imaging system that allows for naturalistic brain mapping, his research aims to improve early detection of brain function alterations associated with ASD, which is crucial for timely intervention and better outcomes.

Dr. Jeremy Dahl's lab focuses on creating advanced imaging technology to improve the early detection of breast cancer. Their primary project involves developing a specialized ultrasound molecular imaging system designed to target a protein called B7-H3, which is closely associated with breast cancer. This innovative approach aims to enhance diagnostic accuracy and potentially allow for the earlier identification of metastatic disease, ultimately offering better treatment options for patients.

Dr. Henk De Feyter's lab at Yale University focuses on advancing brain tumor imaging techniques, particularly for glioblastoma, which is a common and aggressive type of brain cancer. They are innovating a new MRI-based method called Deuterium Metabolic Imaging (DMI) to detect abnormal glucose metabolism in brain tumors, providing a non-invasive way to monitor tumor progression and treatment response. This research aims to improve diagnosis and treatment strategies for patients with brain tumors by offering a more reliable imaging option compared to traditional methods.

Dr. Parisa Rashidi's lab focuses on improving patient care in intensive care units by developing advanced technology for monitoring delirium, a common and serious condition in hospitalized patients. The lab is creating a system called ADAPT that uses sophisticated algorithms and sensors to track patients' mobility and sleep patterns, helping healthcare providers intervene effectively. The research aims to enhance clinical decision-making and ultimately improve patient outcomes in critical care.

Dr. Yuni K Dewaraja's research lab at the University of Michigan focuses on improving radioligand therapy for prostate cancer. The lab aims to make cancer treatment more personalized by developing methods to calculate the optimal dosage of radiation based on each patient's unique characteristics and response to therapy. By utilizing advanced imaging and modeling techniques, the research seeks to enhance treatment efficacy and reduce side effects for patients.

Dr. Kawin Setsompop's research lab at Stanford focuses on advancing diffusion MRI technology to obtain high-resolution images of the brain. By developing new imaging methods, the lab aims to improve our understanding of brain microstructures and their implications for various neurological disorders. The team's work involves creating innovative tools to capture detailed information about brain connectivity and abnormalities, leading to potential breakthroughs in clinical applications and foundational neuroscience.

Dr. Alexey Dimov's lab focuses on improving the detection of hemorrhagic cysts in patients with autosomal dominant polycystic kidney disease (ADPKD). By developing a technique called quantitative susceptibility mapping (QSM), the lab aims to better identify patients at risk for rapid kidney function decline and optimize treatment strategies. This research has the potential to significantly enhance patient care and outcome by providing earlier and more accurate risk assessments.

Dr. Sepideh Dolatshahi's lab at the University of Virginia focuses on understanding how antibodies are transferred from mothers to their infants through the placenta. By exploring the roles of different receptors involved in this process, the lab aims to optimize maternal vaccination strategies to provide better early-life immunity for newborns. Their work combines experimental biology with mathematical modeling to create more effective vaccines for expectant mothers.

Dr. Anne Watson Draelos’s lab focuses on understanding the factors that contribute to cognitive resilience in Alzheimer’s disease through innovative machine learning techniques. By analyzing various types of biological and environmental data, the lab aims to uncover dynamics that influence how individuals age cognitively and how this knowledge can lead to new therapeutic strategies. The research integrates complex models to not only identify key factors but also test interventions based on predicted results, making the process of validating hypotheses faster and more efficient.

Dr. Bastiaan Driehuys' lab focuses on developing advanced MRI technologies to improve the early detection and diagnosis of lung function issues, particularly related to dyspnea (shortness of breath). Their innovative approach uses hyperpolarized xenon MRI to visualize how well lungs exchange gases, providing detailed insights for better clinical decision-making. The lab aims to create a quick and comprehensive MRI exam that assesses multiple causes of breathlessness, particularly in patients affected by conditions like long COVID.